Track the 药明康德 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 药明康德 has published 23 reports. Market capitalisation: €269.6bn. The latest transaction was reported on 30 September 2021 (Sale). Among the most active insiders: Shuhui Chen(陈曙辉). The full history is free.
23
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
23 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 3,757 of 25,829 companies
70.3
score / 100
Value
56
Quality
85
FCF yld3.3%
Earn yld5.4%
EV/EBITDA13.1x
ROE26%
Gross mgn48%
Net mgn42%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.